1543 / 1851
Risk group
Histology
Adjuvant treatment
With LND
No LND
High
Ib G3
EBRT or BT EBRT (+ chemo)
II G1-2, LVSI -ve
II G3 or LVSI +ve
BT
EBRT
EBRT
EBRT (+ chemo)
III
EBRT (+ chemo)
Colombo N. Radiother Oncol. 2015;117(3):559-81
ESMO-ESGO-ESTRO recommendations 2015
4 risk groups